Foliage Publishes White Paper on Software Product Assessments for the Medical Industry
Nov 27, 2005 - Chicago, IL - Foliage Software Systems, a leading software development and technology consulting firm, recently published a new white paper that is being featured at the RSNA Annual Conference. The paper addresses the importance of taking a “look before you leap” approach to next generation software development, and it outlines a ten step methodology to ensure that companies take the RIGHT next step.
The approach that Foliage details in the white paper enables medical companies to:
1. Uncover the reliable and intelligible information required to make informed product development decisions,
2. Arrive at the proper product trade-offs that align business and technology goals and increase the probability of market acceptance,
3. Establish and plan solid software product development strategies aimed at achieving profit yielding market windows.
“Since our founding in 1991, Foliage has developed over 200 software-based products for our clients. Our industry insight tells us that companies in the Medical Industry are looking for ways to lower development risk prior to large-scale software development investments,” explained Tim Bowe, Co-CEO of Foliage. “Foliage’s core competence is custom software development and technology consulting, we offer this product assessment methodology as a way for clients to leverage our deep experience in order to reduce that development risk, at a low fixed price, and in a short time frame,” he added.
On a recurring basis, every company faces the issue of determining where to go next with its product development efforts. With this paper, Foliage offers common sense steps that will help clearly define the business and product strategy as it relates to the product under development. A Foliage assessment will clearly define and prioritize the value proposition of the product, collect information about the current product from all of the stakeholders, compare it directly to the documented product drivers, and evaluate the technologies and the software itself.
Product Assessment services are most beneficial to organizations who:
· Are experiencing serious time-to-market or quality problems with their legacy software
· Have multiple software systems due to a merger or acquisition, who need to reduce software duplication and costs
· Need to expand a single-product software platform into a product line, or need to expand product configurability dramatically
· Have large bodies of legacy software that must be migrated forward or folded into new products.
“Clients benefit from Foliage’s product assessment services because these services provide senior management with the peace of mind that the development project is headed in the right direction and that they are indeed developing the right product. Once the right product hits the market on-time the true profit potential is realized,” explained Rich Sullivan, Manager of Foliage’s Medical Division.
For more information, visit Foliage at RSNA in South Building, Hall A, Booth 2506, go to www.foliage.com/medical, or call John Carey at 781-993-5600.
About Foliage:
Foliage, the driving force behind many of today's life- and mission-critical products, provides clients with the business sense, industry insight and technology expertise needed to bring the right products to market faster. Since 1991, Foliage has provided clients with vital insight into the product development process, facilitating better-informed business decisions across the organization. Foliage enables its clients in the aerospace, financial, industrial equipment, medical and semiconductor industries to capture market share and maximize profitability. A privately held company, Foliage is located in Burlington, Massachusetts.
